Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017:2017:6917907.
doi: 10.1155/2017/6917907. Epub 2017 Jan 26.

NOTCH1 Mutations in Aortic Stenosis: Association with Osteoprotegerin/RANK/RANKL

Affiliations

NOTCH1 Mutations in Aortic Stenosis: Association with Osteoprotegerin/RANK/RANKL

Olga Irtyuga et al. Biomed Res Int. 2017.

Abstract

Background. The NOTCH pathway is known to be important in the pathogenesis of calcific aortic valve disease, possibly through regulators of osteoprotegerin (OPG), receptor activator of nuclear factor κB (RANK), and its ligand (RANKL) system. The purpose of the present study was to search for possible associations between NOTCH1 gene mutations and circulating levels of OPG and soluble RANKL (sRANKL) in patients with aortic stenosis (AS). Methods. The study was performed on 61 patients with AS including 31 with bicuspid and 30 with tricuspid aortic valves. We applied a strategy of targeted mutation screening for 10 out of 34 exons of the NOTCH1 gene by direct sequencing. Serum OPG and sRANKL levels were assessed. Results. In total, 6 genetic variants of the NOTCH1 gene including two new mutations were identified in the study group. In an age- and arterial hypertension-adjusted multivariable regression analysis, the serum OPG levels and the OPG/sRANKL ratio were correlated with NOTCH1 missense variants. All studied missense variants in NOTCH1 gene were found in Ca(2+)-binding EGF motif of the NOTCH extracellular domain bound to Delta-like 4. Conclusion. Our results suggest that the OPG/RANKL/RANK system might be directly influenced by genetic variants of NOTCH1 in aortic valve calcification.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interests regarding the publication of this paper.

Figures

Figure 1
Figure 1
Localization of missense mutations in NOTCH1. (a) DNA sequences, characterized by location of the missense mutations in three patients in comparison with the reference sequence of NOTCH1 gene (NG_007458.1). (b) Multiple sequence alignment of wild-type NOTCH1 protein (Uniprot ID: P46531) and mutated variants located in patients. EGF CA domain is a calcium-binding epidermal growth factor-like domain of NOTCH1. The amino acid residues in boxes are mutated positions.
Figure 2
Figure 2
Structure of NOTCH1 EGF CA domain. (a) The sequence alignment of human NOTCH1 EGF CA domain with rat NOTCH1 EGF CA domain of known crystal structure (PDB ID: 4XLW Chain A) visualized in Jalview 2.8.2 [11]. Highly conserved residues (conservation score = 11) are marked as “” and identical residues (conservation score = 10) are marked as “+.” The amino acids in red boxes are mutated positions. (b) Three-dimensional structure of EGF modules of the NOTCH extracellular domain bound to DLL4 [12] visualized by PyMol. Structures of proteins are shown in cartoon representation. Calcium ions are represented as gray spheres. β-D-glucose (BGC) and α-L-fucose (FUC) molecules are highlighted in yellow. Residues of interest E1305, D1267, and R1279 are marked as sticks in red color.
Figure 3
Figure 3
Box and whisker plots the distributions of serum OPG levels in patients with or without NOTCH1 missense variants: 7.9 (5.3, 9.4) and 5.3 (4.6, 7.2), P = 0.044, comparable.

Similar articles

Cited by

References

    1. Vahanian A., Alfieri O., Andreotti F., et al. Guidelines on the management of valvular heart disease (version 2012). The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology and the European Association for Cardio-Thoracic Surgery. European Heart Journal. 2012;33:2451–2496. doi: 10.1093/eurheartj/ehs109. - DOI - PubMed
    1. Venardos N., Nadlonek N. A., Zhan Q., et al. Aortic valve calcification is mediated by a differential response of aortic valve interstitial cells to inflammation. Journal of Surgical Research. 2014;190(1):1–8. doi: 10.1016/j.jss.2014.03.051. - DOI - PMC - PubMed
    1. Li C., Xu S., Gotlieb A. I. The progression of calcific aortic valve disease through injury, cell dysfunction, and disruptive biologic and physical force feedback loops. Cardiovascular Pathology. 2013;22(1):1–8. doi: 10.1016/j.carpath.2012.06.005. - DOI - PubMed
    1. Rajamannan N. M., Evans F. J., Aikawa E., et al. Calcific aortic valve disease: not simply a degenerative process: a review and agenda for research from the national heart and lung and blood institute aortic stenosis working group. Circulation. 2011;124(16):1783–1791. doi: 10.1161/circulationaha.110.006767. - DOI - PMC - PubMed
    1. Thaden J. J., Nkomo V. T., Enriquez-Sarano M. The global burden of aortic stenosis. Progress in Cardiovascular Diseases. 2014;56(6):565–571. doi: 10.1016/j.pcad.2014.02.006. - DOI - PubMed